Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients
Status:
Terminated
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
This is a pilot study to evaluate safety of fondaparinux and enoxaparin in terms of bleeding
and development of thrombocytopenia in the medical ICU population.